Document is current
Any future updates will be listed below
-
Authors
Lambden, Simon
Tomlinson, James
Piper, Sophie
Gordon, Anthony C.
Leiper, James
-
Funding
Funding for this research was provided by:
Research for Patient Benefit Programme (PB-PG-0610-22350)
- License Information
-
More Information
Article History
Received: 31 July 2018
Accepted: 26 November 2018
First Online: 11 December 2018
Ethics approval and consent to participate
: The study received ethics committee approval (Oxford A research ethics committee (12/SC/0014)) and was registered prior to the start of recruitment (ISRCTN20769191).
: Patient consent was secured for participation in this study and publication of relevant results.
: JL and SL are founding directors of and consultants to Critical Pressure ltd.ACG reports that outside of this work he has received speaker fees from Orion Corporation Orion Pharma and Amomed Pharma. He has consulted for Ferring Pharmaceuticals, Tenax Therapeutics, Baxter Healthcare, Bristol-Myers Squibb and GSK and received grant support from Orion Corporation Orion Pharma, Tenax Therapeutics and HCA International with funds paid to his institution.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
